You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma castrate-resistant prostate cancer (CRPC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)

Suspended
  • Castrate-Resistant Prostate Cancer
  • LIGHT-PSMA-CART cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Jan 25, 2023

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 2, 2021

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

Not yet recruiting
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
  • TmPSMA-02 CAR T Cells
  • (no location specified)
Sep 13, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Prostate Cancer Trial in Houston (Alpharadin)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 16, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer, mCRPC
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
Dec 8, 2022

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Castrate-Resistant Prostate Cancer Trial in Hangzhou (PD1-PSMA-CART cells)

Recruiting
  • Castrate-Resistant Prostate Cancer
  • PD1-PSMA-CART cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Feb 26, 2022

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

Prostate Cancer Trial in Philadelphia (CART-PSMA-TGFßRDN cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Prostate Cancer
  • CART-PSMA-TGFβRDN cells
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 17, 2022

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023